EUVIMEDScopri EUVIMED
Open access

Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder

Amber Davis, Kathryn Van Eck, Nikeea Copeland-Linder, Karen Phuong, Harolyn M E Belcher

Journal of Autism and Developmental Disorders · 2024

DOI: 10.1007/s10803-023-05971-2 ↗

At a glance

Journal article in Journal of Autism and Developmental Disorders, 2024. Written by Amber Davis and 4 co-authors. Institution: Department of Pediatrics, Johns Hopkins University, School of Medicine, Baltimore, USA. Major MEDLINE topics: COVID-19, Autism Spectrum Disorder, Hospitalization, Comorbidity. Cited 7 times so far (Crossref); 28 references. The full text is freely available in PubMed Central. Funded by: NICHD NIH HHS, Kennedy Krieger Institute, Office for Health, Equity, Inclusion, and Diversity, Eunice Kennedy Shriver National Institute of Child Health and Human Development.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Autism spectrum disorder (ASD) is a neuropsychiatric condition that may be associated with negative health outcomes. This retrospective cohort study reveals the odds of hospitalization and mortality based on ASD for a population of insured patients with COVID-19. The odds of hospitalization and mortality for people with ASD were found to be greater than individuals without ASD when adjusted for sociodemographic characteristics. Hospitalization and mortality was associated with a dose-response increase to comorbidity counts (1 to 5+). Odds of mortality remained greater for those with ASD when adjusting for comorbid health conditions. ASD is a risk factor for COVID-19 mortality. Comorbid health conditions play a particular role in increasing the odds of COVID-19 related hospitalization and death for ASD patients.

Subjects

MeSH terms (MEDLINE)

COVID-19Autism Spectrum DisorderHospitalizationComorbidityHumansMaleFemaleUnited StatesRetrospective StudiesAdultAdolescentMiddle AgedChildYoung AdultSARS-CoV-2Risk FactorsChild, PreschoolInsurance, HealthAged

Author keywords

Autism spectrum disorderCOVID-19 pandemicMortalityMultimorbidities

Authors and institutions

  • Department of Pediatrics, Johns Hopkins University, School of Medicine, Baltimore, USA.
  • Office for Health, Equity, Inclusion, and Diversity, Kennedy Krieger Institute, Baltimore, USA.
  • Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, School of Medicine, Baltimore, USA.
  • Kennedy Krieger Institute, Center for Diversity in Public Health Leadership Training, 716 North Broadway, Baltimore, MD, 21205, USA.
  • Brandeis University, Waltham, USA.
  • Department of Pediatrics, Johns Hopkins University, School of Medicine, Baltimore, USA. Belcher@kennedykrieger.org.

Funding

  • NICHD NIH HHS
  • Kennedy Krieger Institute, Office for Health, Equity, Inclusion, and Diversity
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development

Cite

APA

Davis, A., Van Eck, K., Copeland-Linder, N., Phuong, K., & Belcher, H. M. E. (2024). Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. https://doi.org/10.1007/s10803-023-05971-2

Vancouver

Davis A, Van Eck K, Copeland-Linder N, Phuong K, Belcher HME. Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 2024. doi:10.1007/s10803-023-05971-2

BibTeX
@article{Davis2024,
  author = {Davis, Amber and Van Eck, Kathryn and Copeland-Linder, Nikeea and Phuong, Karen and Belcher, Harolyn M E},
  title = {Hospitalization and Mortality for Insured Patients in the United States with COVID-19 with and without Autism Spectrum Disorder},
  journal = {Journal of Autism and Developmental Disorders},
  year = {2024},
  doi = {10.1007/s10803-023-05971-2}
}
Start for free →